The US Food & Drug Administration has given Azimuth Sleep Solutions’ “PortPatch” Emergency Use Authorization as a ventilator accessory during the COVID-19 pandemic.
Made of N99-rated filter material, the patent-pending PortPatch is intended to reduce the spread of airborne particulates through the exhalation ports, anti-asphyxia valves, and carbon dioxide vents on full-face or non-rebreathing CPAP and other ventilation masks.
[RELATED: Combo CPAP/Filter Mask by Circadiance Gets FDA Emergency Use Authorization]
A sleep lab near Azimuth’s headquarters in Memphis, Tenn, has been using the filters resume CPAP titration studies, according to the manufacturer, which adds that PortPatch can also be used by patients on their CPAP masks at home.
